☆ 4.6 Article

Moderators of ayahuasca's biological antidepressant action

FRONTIERS IN PSYCHIATRY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Substance Abuse

Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey

Daniel Perkins et al.

Summary: Emerging evidence suggests that consuming ayahuasca in naturalistic settings is associated with lower self-reported current consumption of alcohol and other drugs, especially for those with prior substance use disorders. This association remains significant even after adjusting for religious or social group effects.

DRUG AND ALCOHOL REVIEW (2022)

添加到收藏夹

Review Psychiatry

Psychedelic medicines for mood disorders: current evidence and clinical considerations

Jerome Sarris et al.

Summary: Recent studies have found that medicinal psychedelics can modulate brain networks, promote neurogenesis and neuroplasticity. Psilocybin and N,N-dimethyltryptamine/ayahuasca have been found to effectively treat depression, while lysergic acid diethylamide has anxiolytic effects. However, the effects of microdosing psychedelics on mood improvement are still controversial.

CURRENT OPINION IN PSYCHIATRY (2022)

添加到收藏夹

Article Neurosciences

Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults

Conor H. Murray et al.

Summary: Classical psychedelics like psilocybin and LSD are being investigated for their potential therapeutic effects in psychiatry. While most studies use high doses, there are reports of beneficial effects of microdosing these drugs. This study found that low doses of LSD resulted in cortical desynchronization and reduced ERP amplitudes, similar to effects seen with higher doses of psychedelics.

PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Psychology, Multidisciplinary

Pathophysiology of Major Depression by Clinical Stages

Ana Cecilia de Menezes Galvao et al.

Summary: The study found that patients with first episode MDD had higher levels of CAR and SC compared to controls, while patients with treatment-resistant depression had lower levels of SC and CAR but higher levels of mBDNF and CRP than controls. The severity of depressive symptoms and poor sleep quality were associated with low levels of SC and CAR, and high levels of mBDNF. These findings suggest a strong relationship between clinical stages of MDD and changes in relevant biological markers.

FRONTIERS IN PSYCHOLOGY (2021)

添加到收藏夹

Article Neurosciences

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Friederike Holze et al.

Summary: This study evaluated the subjective and autonomic effects of different doses of LSD in healthy subjects. It found that LSD displayed dose-proportional pharmacokinetics and dose-dependently induced subjective responses, with a ceiling effect observed for good drug effects at 100 μg. The results suggest that future LSD research may benefit from dose finding based on these findings, and that the full psychedelic effects of LSD are primarily mediated by serotonin 5-HT2A receptor activation.

NEUROPSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Antonio Inserra et al.

Summary: Psychedelic compounds are emerging as potential novel therapeutics in psychiatry, with their main effects mediated through the modulation of neurotransmitter systems, immunity, and neuroplasticity. Promising results suggest an opportunity for improvement in the treatment of psychiatric disorders, an area that has seen limited advancement in the past 20 years. Studies are underway to separate the psychedelic effects from the therapeutic effects of these compounds, aiming to provide more effective treatment options.

PHARMACOLOGICAL REVIEWS (2021)

添加到收藏夹

Review Neurosciences

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

Nicole L. Galvao-Coelho et al.

Summary: Classic serotonergic psychedelics show moderate to significant improvements in mood and depressive symptoms for both healthy volunteers and patients with mood disorders, with enduring effects especially notable in the longer term.

PSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Potential biomarkers of major depression diagnosis and chronicity

Ana Cecilia de Menezes Galvao et al.

Summary: Specific biomarkers (CAR, SC, mBDNF, and PSQI) show potential in evaluating MDD chronicity, but not for diagnosis. These findings can contribute to further research aiming to develop a stronger model for commercial use in psychiatric clinical practice.

PLOS ONE (2021)

添加到收藏夹

Article Neurosciences

Increased sensitivity to strong perturbations in a whole-brain model of LSD

Beatrice M. Jobst et al.

Summary: Research using a whole-brain computational model revealed neurodynamic changes induced by LSD, showing increased dynamical complexity after LSD intake on a global level, and the largest differences within the limbic network, the visual network, and the default mode network.

NEUROIMAGE (2021)

添加到收藏夹

Article Medicine, General & Internal

Trial of Psilocybin versus Escitalopram for Depression

Robin Carhart-Harris et al.

Summary: The study compared the efficacy of psilocybin and escitalopram in treating patients with major depressive disorder. While there was no significant difference in antidepressant effects between the two drugs at week 6, secondary outcomes generally favored psilocybin over escitalopram, though these results were not adjusted for multiple comparisons. Larger and longer trials are needed to further compare psilocybin with established antidepressants.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Psychiatry

Spontaneous and deliberate creative cognition during and after psilocybin exposure

N. L. Mason et al.

Summary: This study demonstrated that psilocybin can enhance creative thinking acutely while decreasing task-based creativity, and can increase the number of novel ideas seven days later. Brain imaging research indicated that the effects of psilocybin on creativity are linked to connectivity within and between networks in the default mode network.

TRANSLATIONAL PSYCHIATRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers

Nadia R. P. W. Hutten et al.

Summary: The study found that single low doses of LSD can significantly increase BDNF levels in healthy volunteers in a short period of time, providing a new direction for researching the use of LSD in patient populations.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

添加到收藏夹

Article Clinical Neurology

Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin

Oskar Hougaard Jefsen et al.

Summary: The study demonstrates that psilocybin rapidly induces gene expression related to neuroplasticity, biased towards the prefrontal cortex, compared to the hippocampus. This provides further evidence for the rapid plasticity-promoting effects of psilocybin.

JOURNAL OF PSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Article Neurosciences

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Friederike Holze et al.

NEUROPSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Article Neurosciences

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

Malin Uthaug et al.

PSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

Psychedelic Psychiatry's Brave New World

David Nutt et al.

CELL (2020)

添加到收藏夹

Article Clinical Neurology

Subacute effects of the psychedelic ayahuasca on the salience and default mode networks

Lorenzo Pasquini et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca

Nicole Leite Galvao-Coelho et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Review Neurosciences

Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness

Jonathan Hamill et al.

CURRENT NEUROPHARMACOLOGY (2019)

添加到收藏夹

Article Psychology, Clinical

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

Fernanda Palhano-Fontes et al.

PSYCHOLOGICAL MEDICINE (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial

Richard J. Zeifman et al.

FRONTIERS IN PHARMACOLOGY (2019)

添加到收藏夹

Article Psychology, Multidisciplinary

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial

Raissa Nobrega de Almeida et al.

FRONTIERS IN PSYCHOLOGY (2019)

添加到收藏夹

Review Pathology

Blood biomarkers and treatment response in major depression

Cristina Mora et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)

添加到收藏夹

Review Behavioral Sciences

Treatment resistant depression: A multi-scale, systems biology approach

Huda Akil et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)

添加到收藏夹

Article Psychiatry

Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls

Ana C. de Menezes Galvao et al.

FRONTIERS IN PSYCHIATRY (2018)

添加到收藏夹

Article Neurosciences

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution

M. V. Uthaug et al.

PSYCHOPHARMACOLOGY (2018)

添加到收藏夹

Editorial Material Psychiatry

Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!

Michael P. Hengartner et al.

FRONTIERS IN PSYCHIATRY (2018)

添加到收藏夹

Editorial Material Psychiatry

Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression When Enough Is Enough

Charles R. Conway et al.

JAMA PSYCHIATRY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca

A. Viol et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Robin L. Carhart-Harris et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Clinical Neurology

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans

Marta Valle et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Neurosciences

LSD-Induced Entropic Brain Activity Predicts Subsequent Personality Change

A. V. Lebedev et al.

HUMAN BRAIN MAPPING (2016)

添加到收藏夹

Article Pharmacology & Pharmacy

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study

Rafael Faria Sanches et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Roland R. Griffiths et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Stephen Ross et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization

Ede Frecska et al.

FRONTIERS IN PHARMACOLOGY (2016)

添加到收藏夹

Article Psychiatry

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin L. Carhart-Harris et al.

LANCET PSYCHIATRY (2016)

添加到收藏夹

Review Toxicology

The hallucinogenic world of tryptamines: an updated review

Ana Margarida Araujo et al.

ARCHIVES OF TOXICOLOGY (2015)

添加到收藏夹

Article Neurosciences

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Yasmin Schmid et al.

BIOLOGICAL PSYCHIATRY (2015)

添加到收藏夹

Article Neurosciences

Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations

Michael Kometer et al.

PSYCHOPHARMACOLOGY (2015)

添加到收藏夹

Article Psychiatry

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Flavia de L. Osorio et al.

REVISTA BRASILEIRA DE PSIQUIATRIA (2015)

添加到收藏夹

Article Multidisciplinary Sciences

The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network

Fernanda Palhano-Fontes et al.

PLOS ONE (2015)

添加到收藏夹

Article Clinical Neurology

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

Peter Gasser et al.

JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)

添加到收藏夹

Article Neurosciences

Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion

Draulio B. de Araujo et al.

HUMAN BRAIN MAPPING (2012)

添加到收藏夹

Article Neurosciences

Pharmacology of ayahuasca administered in two repeated doses

Rafael G. dos Santos et al.

PSYCHOPHARMACOLOGY (2012)

添加到收藏夹

Article Pharmacology & Pharmacy

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca A Comparative Study With D-Amphetamine

Rafael G. dos Santos et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)

添加到收藏夹

Editorial Material Psychiatry

Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders

Thomas Insel et al.

AMERICAN JOURNAL OF PSYCHIATRY (2010)

添加到收藏夹

Review Clinical Neurology

Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression

Hiroshi Kunugi et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)

添加到收藏夹

Article Nursing

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

Robert H. Howland

JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2009)

添加到收藏夹

Article Social Sciences, Interdisciplinary

Understanding and using mediators and moderators

Amery D. Wu et al.

SOCIAL INDICATORS RESEARCH (2008)

添加到收藏夹

Article Plant Sciences

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members

R. G. Santos et al.

JOURNAL OF ETHNOPHARMACOLOGY (2007)

添加到收藏夹

Review Substance Abuse

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids

Robert S. Gable

ADDICTION (2007)

添加到收藏夹

Article Neurosciences

Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant

J Riba et al.

PSYCHOPHARMACOLOGY (2006)

添加到收藏夹

Article Neurosciences

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study

F Hasler et al.

PSYCHOPHARMACOLOGY (2004)

添加到收藏夹

Article Psychiatry

Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression

M Zimmerman et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2004)

添加到收藏夹

Article Neurosciences

Effects of the South American psychoactive beverage Ayahuasca on regional brain electrical activity in humans: A functional neuroimaging study using low-resolution electromagnetic tomography

J Riba et al.

NEUROPSYCHOBIOLOGY (2004)

添加到收藏夹

Article Psychiatry

Mediators and moderators of treatment effects in randomized clinical trials

HC Kraemer et al.

ARCHIVES OF GENERAL PSYCHIATRY (2002)

添加到收藏夹

Article Neurosciences

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

J Riba et al.

PSYCHOPHARMACOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.